Evidence map›Paper›PMID 22009226›Full record

ArticleJournal of molecular evolution2011

Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets.

Nancy Y Villa, Patricia Moussatche, Stephen G Chamberlin, Anuj Kumar, Thomas J Lyons

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular evolution, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. The Mechanistic Targets of Antifungal Agents: An Overview.Mini reviews in medicinal chemistry · 2016
    Review
  11. Article
  12. PAQR3: a novel tumor suppressor gene.American journal of cancer research · 2015
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nancy Y VillaDepartment of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610-0485, USA.
Patricia Moussatche
Stephen G Chamberlin
Anuj Kumar
Thomas J Lyons
Foundation for Applied Molecular Evolution · USUniversity of Florida · USUniversity of Michigan–Ann Arbor · US

Funding

Biochemical and pharmacological studies of human membrane progesterone receptorsR01GM086617 · NIGMS · FOUNDATION FOR APPLIED MOLECULAR EVOLUTN · PI CHAMBERLIN, STEPHEN G · 2009 to 2013
$1.3M
Probing the mechanisms of signal transduction via adiponectin and its receptorsR21DK074812 · NIDDK · UNIVERSITY OF FLORIDA · PI LYONS, THOMAS J · 2006 to 2007
$260k
NIDDK NIH HHS R21 DK074812NIGMS NIH HHS R01 GM086617NIGMS NIH HHS R01 GM086617-01
6 · The paper itself

Abstract

Proteins belonging to the Progestin and AdipoQ Receptor (PAQR) superfamily of membrane bound receptors are ubiquitously found in fungi. Nearly, all fungi possess two evolutionarily distinct paralogs of PAQR protein, which we have called the PQRA and PQRB subtypes. In the model fungus Saccharomyces cerevisiae, these subtypes are represented by the Izh2p and Izh3p proteins, respectively. S. cerevisiae also possesses two additional PQRA-type receptors called Izh1p and Izh4p that are restricted to other species within the "Saccharomyces complex". Izh2p has been the subject of several recent investigations and is of particular interest because it regulates fungal growth in response to proteins produced by plants and, as such, represents a new paradigm for interspecies communication. We demonstrate that IZH2 and IZH3 gene dosage affects resistance to polyene antifungal drugs. Moreover, we provide additional evidence that Izh2p and Izh3p negatively regulate fungal filamentation. These data suggest that agonists of these receptors might make antifungal therapeutics, either by inhibiting fungal development or by sensitizing fungi to the toxic effects of current antifungal therapies. This is particularly relevant for pathogenic fungi such as Candida glabrata that are closely related to S. cerevisiae and contain the same complement of PAQR receptors.

Indexed as

PhylogenyAmino Acid MotifsAmino Acid SequenceAntifungal AgentsChromosome DuplicationChromosomes, FungalConserved SequenceDrug Resistance, FungalEvolution, MolecularGene DosageGenome, FungalHydrophobic and Hydrophilic InteractionsHyphaeMembrane ProteinsMolecular Sequence DataNystatinAntifungal AgentsIZH2 protein, S cerevisiaeIzh3 protein, S cerevisiaeMembrane ProteinsNystatinPolyenesReceptors, Cell SurfaceSaccharomyces cerevisiae Proteins

Identifiers

PMID22009226
PMCPMC3236824
OpenAlexW2021166231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.